The ELISA test for MIP-3 alpha/CCL20 allows the quantification of human MIP-3α in serum, plasma or the human cell culture medium. The dosage will only recognize natural and recombinant Hu MIP-3α. Principle of the method The...
The ELISA test for MIP-3 alpha/CCL20 allows the quantification of human MIP-3α in serum, plasma or the human cell culture medium. The dosage will only recognize natural and recombinant Hu MIP-3α. Method principle The ELISA solid phase sandwich test of human MIP-3α (immuno-enzymatic test) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-vested in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bound to immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
Inflammatory 3-alpha macrophage (MIP-3 alpha), also known as CCL20, is expressed in the liver, lungs, lymph nodes, and peripheral blood lymphocytes. MIP-3 alpha is highly regulated by inflammatory signals and regulated by the anti-inflammatory cytokine IL-10. MIP-3 alpha reports via the G-protein-coupled receptor, CCR6, and acts as a chemoattractant for lymphocytes and dendritic cells.
Sensitivity
Sensitivity of the dosage: 1.5 pg/ml.
Measurement range
Dose range: 0.8-600 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Intradose variation coefficient < 10%, interdose < 12%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15434933 |
| Specifications |
| Accession number | P78556 |
| Dose range | 0.8-600 pg/ml |
| Sensitivity of the dosage | 1.5 pg/ml |
| Calibration range | 1.5 pg/ml to 600 pg/ml |
| Dose | ELISA solid-phase sandwich |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Protein family | Chemiokine & receptors |
| Type of sample | Serum, Surnatant, Surnatant |
| Specificity | This ELISA kit shows no cross-reactivity with the cytokines tested: Angiogenin, BDNF, BLC, ENA-78, FGF-4, IL-1 alpha, IL-1 beta, IL-2, IL-3, IL-4, IL-5, IL-7, IL-8, IL-9, IL-10, IL-11, IL-12 p70, IL-12 p40, IL-13, IL-15, IL-309, IP-10, G-CSF human |
| Sufficient for | 96 dosages |
| Target species | Human |
| For use with (application) | ELISA, protein dosage, protein biology, cancerology, immunology, neuroscience, neurobiology, protein detection, protein analyses |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 6364 |
| Gene symbol(s) | CKb4,Exodus,LARC,MIP-3-alpha,MIP-3a,MIP3A,SCYA20,ST38 |
| Coefficient of inter-dose variation | < 12 % |
| Coefficient of intra-dose variation | < 10 % |
| Contents of kits | Chromogen, Detection Antibody, Diluents, HRP Conjugate, Plate Covers, Pre-coated Plate(s), Stalcon, Stop Solution, Washing Stamp |
| Marker or dye | HRP |
| Quantity | 96 tests |
| Regulatory status | RUO |
| Research disciplines | Immunology |
| Target | Human |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 50 μl; serum, 50 μl; supernatant, 100 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EHCCL20 |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.